design expert software version 13 (dx13 (Stat-Ease inc)
90
Structured Review
Stat-Ease inc
design expert software version 13 (dx13
Design Expert Software Version 13 (Dx13, supplied by Stat-Ease inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/design+expert+software+version+13+(dx13/design+expert+software+version+13++dx13/10__1016_slash_j__jddst__2024__106368-65-19-25
Average 90 stars, based on 1 article reviews
Design Expert Software Version 13 (Dx13, supplied by Stat-Ease inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/design+expert+software+version+13+(dx13/design+expert+software+version+13++dx13/10__1016_slash_j__jddst__2024__106368-65-19-25
Average 90 stars, based on 1 article reviews
design expert software version 13 (dx13 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Software:Article Title: Optimizing Nutraceutical-Loaded Trehalosomes In-Situ Gel for Diabetic Cataract Management: Comprehensive In Vitro and In Vivo Evaluations Article Snippet: This study aimed to develop Baicalin-loaded trehalosomes in situ gel (BA-THs-ISG) for the treatment of cataract, a degenerative eye condition that requires innovative approaches to enhance visual acuity and quality of life.. A 33 D-optimal design was implemented for the preparation and statistical optimization of BA-THs.. Various in-vitro studies were conducted to evaluate the features of the optimized formula, which was subsequently loaded into an optimum ISG to sustain the release pattern. Formulation:Article Title: Optimizing Nutraceutical-Loaded Trehalosomes In-Situ Gel for Diabetic Cataract Management: Comprehensive In Vitro and In Vivo Evaluations Article Snippet: This study aimed to develop Baicalin-loaded trehalosomes in situ gel (BA-THs-ISG) for the treatment of cataract, a degenerative eye condition that requires innovative approaches to enhance visual acuity and quality of life.. A 33 D-optimal design was implemented for the preparation and statistical optimization of BA-THs.. Various in-vitro studies were conducted to evaluate the features of the optimized formula, which was subsequently loaded into an optimum ISG to sustain the release pattern. |